mttpМеждународная торговля и торговая политикаInternational Trade and Trade Policy2410-73952414-4649ФГБОУ ВО "Российский экономический университет им. Г.В. Плеханова"10.21686/2410-7395-2023-3-87-100mttp-629Research ArticleКОНЪЮНКТУРА МИРОВЫХ ТОВАРНЫХ РЫНКОВWORLD COMMODITY MARKETSВАКЦИНЫ КАК ПРОДУКТ ПРОМЫШЛЕННЫХ БИОТЕХНОЛОГИЙ И ОСОБЫЙ ТОВАР НА МЕЖДУНАРОДНОМ РЫНКЕ БИОФАРМПРЕПАРАТОВVACCINES AS A PRODUCT OF INDUSTRIAL BIOTECHNOLOGIES AND A SPECIAL COMMODITY IN THE INTERNATIONAL BIOPHARMACEUTICALS MARKETТитоваЕ. С.TitovaE. S.

Екатерина Сергеевна Титова, кандидат экономических наук, ведущий научный сотрудник научно-исследовательского института развития образования

115054, Москва, Стремянный пер., д. 36

Ekaterina S. Titova, PhD, Leading Researcher of the Education Development Research Institute of the PRUE

36 Stremyanny Lane, Moscow, 115054

Titova.ES@rea.ruШишкинС. С.ShishkinS. S.

Сергей Сергеевич Шишкин, доктор биологических наук, профессор, главный научный сотрудник аналитической группы ФИЦ Биотехнологии РАН

 119071, Москва, Ленинский проспект, д. 33, стр. 2

Sergey S. Shishkin, Doctor of Biological Sciences, Professor,Senior Researcher of the Analytical Group of the Research Centre of Biotechnology RAS

33, Building 2, Leninsky Prospect, Moscow, 119071

sergeyshishkin@yandex.ruРоссийский экономический университет имени Г. В. ПлехановаРоссияPlekhanov Russian University of EconomicsRussian FederationФедеральный исследовательский центр «Фундаментальные основы биотехнологии» Российской академии наукРоссияFederal Research Centre “Fundamentals of biotechnology” of the Russian Academy of SciencesRussian Federation2023151020239387100Copyright © Титова Е.С., Шишкин С.С., 20232023Титова Е.С., Шишкин С.С.Titova E.S., Shishkin S.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://mttp.rea.ru/jour/article/view/629

Состояние мирового рынка биофармпрепаратов в настоящее время приобретает особое значение не только как важнейшая экономическая характеристика и условие успешной организации здравоохранения в разных странах, но и как гарантия безопасности от возможных пандемий. Особую роль при этом играют разнообразные вакцины, производство которых стало одним из секторов современной биоэкономики. Биоэкономика как вид деятельности базируется на промышленных биотехнологиях и новых подходах, основанных на знаниях, для эффективного производства биопродуктов, вырабатываемых из природных ресурсов, и ориентирована на решение экологических, политических и социальных вопросов для обеспечения устойчивого развития. Цель статьи – изучение общих тенденций производства и оборота вакцин на рынке биофармпрепаратов с учетом пандемии COVID-19. Приводятся данные об осложнениях после вакцинации и проявлениях конкуренции фармкомпаний на рынке вакцин с различными последствиями. Сделан вывод, что эффективное функционирование мирового рынка вакцин можно рассматривать как важный элемент устойчивого развития на пути к достижению защиты граждан от опасных болезней и обеспечению социального благополучия ввиду развития биотехнологий. 

Global biopharmaceutical market state is currently of particular importance not only as a primary economic characteristic and a condition for the successful healthcare organization in different countries, but also as a safety from possible pandemics guarantee. Various vaccines production plays a special role becoming one of the modern bioeconomy sectors. The bioeconomy, as an activity, is based on industrial biotechnologies and new knowledgebased approaches for the efficient bioproducts production derived from natural resources, and is focused on solving various environmental, as well as political and even social issues for sustainable development. The purpose of the article is to study the general trends in the production and turnover of vaccines on the biopharmaceutical market, taking into account the COVID-19 pandemic. Data on vaccination complications and manifestations of pharmaceutical companies' competition in the vaccine market with various consequences are presented. It is concluded that the effective functioning of the global vaccine market can be considered as an important element of sustainable development on the way to achieving the protection of citizens from dangerous diseases and ensuring social welfare due to the development of biotechnologies. 

биоэкономикарынок биофармпрепаратовCOVID-19bioeconomybiopharmaceuticals marketCOVID-19ReferencesАрсентьева И. И. Трансформация медицинской и вакцинной дипломатии в эпоху COVID-19 // Вестник МГИМО-Университета. – 2022. – Т. 15. – № 5. – С. 182–207.Arsenteva I. I. Transformatsiya meditsinskoy i vaktsinnoy diplomatii v epokhu COVID-19 [Transformation of Medical and Vaccine Diplomacy in the Era of COVID-19]. Vestnik MGIMO-Universiteta [Bulletin of MGIMOUniversity], 2022, Vol. 15, No. 5, pp. 182–207. (In Russ.).Горошко Н. В., Пацала С. В., Емельянова Е. К. Рынок COVID-19- вакцин как новый сегмент мирового вакцинного рынка // Вестник Кемеровского государственного университета. Серия: Политические, социологические и экономические науки. – 2021. – Т. 6. – № 2 (20). – С. 178–190.Goroshko N. V., Patsala S. V., Emelyanova E. K. Rynok COVID-19- vaktsin kak novyy segment mirovogo vaktsinnogo rynka [The Market for COVID-19 Vaccines as a New Segment of the Global Vaccine Market]. Vestnik Kemerovskogo gosudarstvennogo universiteta. Seriya: Politicheskie, sotsiologicheskie i ekonomicheskie nauki [Bulletin of the Kemerovo State University. Series: Political, Sociological and Economic Sciences], 2021, Vol. 6, No. 2 (20), pp. 178– 190. (In Russ.).Наркевич И. А., Трухин В. П., Басакина И. И., Барабанова А. И., Тернинко Т. М. Анализ структуры и ассортимента вакцин на Российском фармацевтическом рынке // Вестник Воронежского государственного университета. Серия: Химия. Биология. Фармация. – 2019. – № 4. – С. 94–100.Narkevich I. A., Trukhin V. P., Basakina I. I., Barabanova A. I., Terninko T. M. Analiz struktury i assortimenta vaktsin na Rossiyskom farmatsevticheskom rynke [Analysis of the Structure and Range of Vaccines in the Russian Pharmaceutical Market]. Vestnik Voronezhskogo gosudarstvennogo universiteta. Seriya: Khimiya. Biologiya. Farmatsiya. [Bulletin of the Voronezh State University. Series: Chemistry. Biology. Pharmacy]. 2019, No. 4, pp. 94– 100. (In Russ.).Оперативные данные о COVID-19. – URL: https://xn-- 80aesfpebagmfblc0a.xn--p1ai/Operativnye dannye o COVID-19 [Operational Data on COVID-19]. (In Russ.). Available at: https://xn--80aesfpebagmfblc0a.xn--p1ai/Погарская А. С., Конфино К. В. Реализация подхода холодовой цепи при транспортировке и хранении иммунобиологических препаратов // Проблемы социальной гигиены, здравоохранения и истории медицины. – 2022. – № 30 (4). – C. 666–672. – DOI: 10.32687/0869-866X-2022-30-4-666-672Pogarskaya A. S., Konfino K. V. Realizatsiya podkhoda kholodovoy tsepi pri transportirovke i khranenii immunobiologicheskikh preparatov [Implementation of the Cold Chain Approach in the Transportation and Storage of Immunobiological Preparations]. Problemy sotsialnoy gigieny, zdravookhraneniya i istorii meditsiny [Problems of Social Hygiene, Health Care and the History of Medicine], 2022, No. 30 (4), pp. 666–672. (In Russ.). DOI: 10.32687/0869-866X-2022-30-4-666-672Титова Е. С., Шишкин С. С., Штыхно Д. А. Биоэкономика – один из путей к устойчивому развитию регионов // Федерализм. – 2023. – Т. 28. – № 1 (109). – С. 56–79. – DOI: 10.21686/2073-1051-2023-1-56-79Titova E. S., Shishkin S. S., Shtykhno D. A. Bioekonomika – odin iz putey k ustoychivomu razvitiyu regionov [Bioeconomy as One of the Ways to Sustainable Development of Russian Regions]. Federalizm [Federalizm], 2023, Vol. 28, No. 1 (109), pp. 56–79. (In Russ.). DOI: 10.21686/2073-1051-2023-1-56-7940 лет без оспы. В ВОЗ напоминают о важном достижении человечества. – URL: https://news.un.org/ru/story/2019/12/136884140 let bez ospy. V VOZ napominayut o vazhnom dostizhenii chelovechestva [40 Years without Smallpox. WHO Reminds about the Important Achievement of Mankind]. (In Russ.). Available at: https://news. un.org/ru/story/2019/12/1368841Aguilar A., Bochereau L., Matthiessen L. Biotechnology as the Engine for the Knowledge-Based Bio-Economy // Biotechnology & Genetic Engineering Reviews. – 2010. – Vol. 26. – P. 371–388. – DOI: 10.5661/bger-26-371Aguilar A., Bochereau L., Matthiessen L. Biotechnology as the Engine for the Knowledge-Based Bio-Economy. Biotechnology & Genetic Engineering Reviews, 2010, Vol. 26, pp. 371–388. DOI: 10.5661/bger-26-371Bayani F., Hashkavaei N. S., Arjmand S. et al. An Overview of the Vaccine Platforms to Combat COVID-19 with a Focus on the Subunit Vaccines // Progress in Biophysics and Molecular Biology. – 2023. – Vol. 178. – P. 32–49. – DOI: 10.1016/j.pbiomolbio.2023.02.004Bayani F., Hashkavaei N. S., Arjmand S. et al. An Overview of the Vaccine Platforms to Combat COVID-19 with a Focus on the Subunit Vaccines. Progress in Biophysics and Molecular Biology, 2023, Vol. 178, pp 32–49. DOI: 10.1016/j.pbiomolbio.2023.02.004Catalani V., Townshend H. D., Prilutskaya M. et al. Profiling the Vendors of COVID-19 Related Product on the Darknet: An Observational Study // Emerging Trends in Drugs, Addictions and Health. – 2023. – Vol. 3. – P. 100051. – DOI: 10.1016/j.etdah.2023.100051Catalani V., Townshend H. D., Prilutskaya M. et al. Profiling the Vendors of COVID-19 Related Product on the Darknet: an Observational Study. Emerging Trends in Drugs, Addictions and Health, 2023, Vol. 3, p. 100051. DOI: 10.1016/j.etdah.2023.100051Deshar P. A Global Look into the Prospects of Bioeconomy // Yrkeshögskolan Novia, 2016. – URL: http://www.theseus.fi/handle/10024/ 115759Deshar P. A Global Look into the Prospects of Bioeconomy. Yrkeshögskolan Novia, 2016. Available at: http://www.theseus.fi/handle/ 10024/115759Huddart J. E. A., Crawford A. J., Luna-Tapia A. L. et al. EBP-Colombia and the Bioeconomy: Genomics in the Service of Biodiversity Conservation and Sustainable Development // Proceedings of the National Academy of Sciences of the USA. – 2022. – Vol. 119 (4). –P. e2115641119. – DOI: 10.1073/ pnas.2115641119Huddart J. E. A., Crawford A. J., Luna-Tapia A. L. et al. EBPColombia and the Bioeconomy: Genomics in the Service of Biodiversity Conservation and Sustainable Development. Proceedings of the National Academy of Sciences of the USA, 2022, Vol. 119 (4), p. e2115641119. DOI: 10.1073/ pnas.2115641119Leigang Jin, Leiluo Geng, Ranyao Yang, Aimin Xu. Fibroblast Growth Factor-Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications // Annual Review of Pharmacology and Toxicology. – 2023. – Vol. 63. – P. 359–382. – DOI: 10.1146/annurev-pharmtox-032322- 093904Leigang Jin, Leiluo Geng, Ranyao Yang, Aimin Xu. Fibroblast Growth Factor-Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications. Annual Review of Pharmacology and Toxicology, 2023, Vol. 63, p. 359–382. DOI: 10.1146/annurev-pharmtox-032322-093904Kesik-Brodacka M. Progress in Biopharmaceutical Development // Biotechnology and Applied Biochemistry. – 2018. – Vol. 65 (3). – P. 306–322. – DOI: 10.1002/bab.1617Kesik-Brodacka M. Progress in Biopharmaceutical Development. Biotechnology and Applied Biochemistry, 2018, Vol. 65 (3), p. 306–322. DOI: 10.1002/bab.1617Kircher M., Maurer K-H. Herzberg D. KBBE: The Knowledge-Based Bioeconomy: Concept, Status and Future Prospects // EFB Bioeconomy Journal. – 2022. – Vol. 2. – P. 100034. – DOI: 10.1016/j.bioeco.2022.100034Kircher M., Maurer K-H. Herzberg D. KBBE: The Knowledge-Based Bioeconomy: Concept, Status and Future Prospects. EFB Bioeconomy Journal, 2022, Vol. 2, p. 100034. DOI: 10.1016/j.bioeco.2022.100034Kumar V., Kumar S., Sharma P. C. Recent Advances in the Vaccine Development for the Prophylaxis of SARS Covid-19 // International Immunopharmacology. – 2022. – Vol. 111. – P. 109175. – DOI: 10.1016/j.intimp. 2022.109175Kumar V., Kumar S., Sharma P. C. Recent Advances in the Vaccine Development for the Prophylaxis of SARS Covid-19. International Immunopharmacology, 2022, Vol. 111, p. 109175. DOI: 10.1016/j.intimp. 2022.109175Logunov D. Y., Dolzhikova I. V., Shcheblyakov D. V. et al. Gam-COVIDVac Vaccine Trial Group. Safety and Efficacy of an rAd26 and rAd5 VectorBased Heterologous Prime-Boost COVID-19 Vaccine: an Interim Analysis of a Randomised Controlled Phase 3 Trial in Russia // Lancet. – 2021. – Vol. 397 (10275). – P. 671–681. – DOI: 10.1016/S0140-6736(21)00234-8Logunov D. Y., Dolzhikova I. V., Shcheblyakov D. V. et al. GamCOVID-Vac Vaccine Trial Group. Safety and Efficacy of an rAd26 and rAd5 Vector-Based Heterologous Prime-Boost COVID-19 Vaccine: an Interim Analysis of a Randomised Controlled Phase 3 Trial in Russia. Lancet, 2021, Vol. 397 (10275), pp. 671–681. DOI: 10.1016/S0140-6736(21)00234-8Miao G., Chen Z., Cao H. et al. From Immunogen to COVID-19 Vaccines: Prospects for the Post-Pandemic Era // Biomedicine & Pharmacotherapy. – 2023. – Vol. 158. – P. 114208. – DOI: 10.1016/j.biopha. 2022.114208Miao G., Chen Z., Cao H. et al. From Immunogen to COVID-19 Vaccines: Prospects for the Post-Pandemic Era. Biomedicine & Pharmacotherapy, 2023, Vol. 158, p. 114208. DOI: 10.1016/j.biopha. 2022.114208Mitragotri S., Burke P. A., Langer R. Overcoming the Challenges in Administering Biopharmaceuticals: Formulation and Delivery Strategies // Nature Reviews Drug Discovery. – 2014. – Vol. 13 (9). – P. 655–672. – DOI: 10.1038/nrd4363Mitragotri S., Burke P. A., Langer R. Overcoming the Challenges in Administering Biopharmaceuticals: Formulation and Delivery Strategies. Nature Reviews Drug Discovery, 2014, Vol. 13 (9), pp. 655–672. DOI: 10.1038/ nrd4363Ndwandwe D., Wiysonge C. S. COVID-19 vaccines // Current Opinion in Immunology. – 2021. – Vol. 71. – P. 111–116. – DOI: 10.1016/j.coi.2021.07.003Ndwandwe D., Wiysonge C. S. COVID-19 vaccines. Current Opinion in Immunology, 2021, Vol. 71, pp. 111–116. DOI: 10.1016/j.coi.2021.07.003Nielsen J., Tillegreen C. B., Petranovic D. Innovation trends in industrial biotechnology // Trends in Biotechnology. – 2022. – Vol. 40 (10). – P. 1160– 1172. – DOI: 10.1016/j.tibtech.2022.03.007Nielsen J., Tillegreen C. B., Petranovic D. Innovation trends in industrial biotechnology. Trends in Biotechnology, 2022, Vol. 40 (10), pp. 1160– 1172. DOI: 10.1016/j.tibtech.2022.03.007Pavli A., Maltezou H. C. Travel vaccines throughout history // Travel Medicine and Infectious Disease. – 2022. – Vol. 46. – P. 102278. – DOI: 10.1016/ j.tmaid.2022.102278Pavli A., Maltezou H. C. Travel vaccines throughout history. Travel Medicine and Infectious Disease, 2022, Vol. 46, p. 102278. DOI: 10.1016/j.tmaid. 2022.102278Pollet J., Chen W. H., Strych U. Recombinant Protein Vaccines, a Proven Approach Against Coronavirus Pandemics // Advanced Drug Delivery Reviews. – 2021. – Vol. 170. – P. 71–82. – DOI: 10.1016/j.addr.2021.01.001Pollet J., Chen W. H., Strych U. Recombinant Protein Vaccines, a Proven Approach Against Coronavirus Pandemics. Advanced Drug Delivery Reviews, 2021, Vol. 170, pp. 71–82. DOI: 10.1016/j.addr. 2021.01.001Song T. J., Shin J. I., Yon D. K. et al. Cerebral Venous Thrombosis after ChAdOx1 nCoV-19 Vaccination: a Systematic Review // European Review for Medical and Pharmacological Sciences. – 2023. – Vol. 27 (1). – P. 404–410. – DOI: 10.26355/eurrev_202301_30894Song T. J., Shin J. I., Yon D. K. et al. Cerebral Venous Thrombosis after ChAdOx1 nCoV-19 Vaccination: a Systematic Review. European Review for Medical and Pharmacological Sciences, 2023, Vol. 27 (1), pp. 404–410. DOI: 10.26355/eurrev_202301_30894Wohlgemuth R., Twardowski T., Aguilar A. Bioeconomy Moving Forward Step by Step – a Global Journey // New Biotechnology. – 2021. – Vol. 61. – P. 22–28. – DOI: 10.1016/j.nbt.2020.11.006Wohlgemuth R., Twardowski T., Aguilar A. Bioeconomy Moving Forward Step by Step – a Global Journey. New Biotechnology, 2021, Vol. 61, pp. 22–28. DOI: 10.1016/j.nbt.2020.11.006

The authors declare that there are no conflicts of interest present.